11 Non-Hormonal Treatment Options for Menopause Symptoms That Are Actually Evidence-Based
When HRT wasn't the right fit, the sheer volume of 'natural alternatives' out there was honestly exhausting — every supplement promising everything, none of them with a clear answer about what the evidence actually said. What helped most was finding the handful of options that had been properly tested, and understanding that non-hormonal doesn't mean ineffective. It just means doing the homework first.
Learn more about Rose →SSRIs and SNRIs (Low-Dose Antidepressants)
Selective serotonin reuptake inhibitors like escitalopram and paroxetine, and SNRIs like venlafaxine, are the most robustly studied non-hormonal options for vasomotor symptoms — hot flashes and night sweats specifically. Multiple randomised controlled trials show they reduce hot flash frequency by 40–60%, which is meaningful, even if not quite at HRT levels. They're particularly relevant for women with a history of hormone-sensitive cancers, where estrogen therapy is contraindicated.
Fezolinetant (Neurokinin B Receptor Antagonist)
Fezolinetant is a newer, non-hormonal prescription medication that works by blocking neurokinin B signalling in the hypothalamus — the pathway now understood to directly trigger vasomotor symptoms when estrogen declines. Phase 3 trial data (the SKYLIGHT studies) showed significant reductions in both frequency and severity of moderate-to-severe hot flashes compared to placebo. It was approved by the FDA in 2023 specifically for menopause-related vasomotor symptoms, making it one of the most targeted non-hormonal options available.
Cognitive Behavioural Therapy (CBT)
CBT adapted specifically for menopause has been tested in well-designed RCTs, including the UK-based MENOS trials, and consistently shown to reduce the perceived bother and impact of hot flashes and night sweats — even when it doesn't reduce their raw frequency. It also has strong evidence for improving menopause-related sleep disturbance, low mood, and anxiety. The mechanism involves changing how the brain processes and responds to temperature dysregulation and stress, not suppressing the symptoms directly.
Clinical Hypnotherapy
Hypnotherapy for hot flashes may sound surprising, but it has earned genuine clinical credibility through RCT data, including a notable trial from Baylor University that showed a 74% reduction in hot flash scores in postmenopausal women. The proposed mechanism involves inducing a state of deep relaxation that reduces the hyperactivated thermoregulatory response driving vasomotor symptoms. It's one of the more underused evidence-based options, likely because it sits outside mainstream medical practice.
Gabapentin
Gabapentin, an anticonvulsant medication also used for nerve pain, has multiple RCTs supporting its use for reducing hot flash frequency and severity, particularly night-time hot flashes that disrupt sleep. It's thought to work by stabilising neuronal excitability in the hypothalamic temperature regulation centres. It's generally considered a second-line option due to side effects including dizziness and sedation, but for women with sleep disruption as a primary complaint, those sedating effects can sometimes be useful.
Oxybutynin
Originally prescribed for overactive bladder, oxybutynin has been studied in RCTs for hot flashes and shown meaningful reductions in vasomotor symptom frequency and severity. A 2023 trial published in JAMA found it performed comparably to some first-line options. It works via anticholinergic pathways rather than any hormonal mechanism, making it a genuinely different pharmacological route for hot flash management.
Pelvic Floor Physical Therapy
For genitourinary symptoms — vaginal dryness, urgency, stress urinary incontinence, and painful sex — pelvic floor physiotherapy has strong evidence, particularly for incontinence where it's a first-line recommendation from major urology bodies worldwide. A trained pelvic floor physiotherapist can address both hypertonic (too tight) and hypotonic (too weak) pelvic floor presentations, both of which become more common as estrogen declines. It addresses the musculoskeletal dimension of genitourinary symptoms that no pill or cream reaches.
Resistance and Weight-Bearing Exercise
Regular resistance training has RCT-level evidence for improving mood, sleep quality, and fatigue in perimenopausal and postmenopausal women, and observational data consistently links it to reduced vasomotor symptom severity. More critically, it's the most evidence-supported intervention for preserving bone density and muscle mass — two areas where declining estrogen creates genuine long-term risk. The dose that appears in clinical literature is at least two sessions per week of progressive resistance training.
Dietary Soy Isoflavones
Soy isoflavones are phytoestrogens that bind weakly to estrogen receptors, and meta-analyses of RCTs show modest but statistically significant reductions in hot flash frequency — roughly a 20% reduction compared to placebo, which is lower than pharmaceutical options but real. The evidence is strongest for dietary soy consumed consistently rather than for highly concentrated supplements, and effects appear more pronounced in women whose gut bacteria can convert daidzein to equol (roughly 30–50% of Western women). They're not a substitute for HRT in severe cases, but as part of a broader approach, the evidence is credible.
Mindfulness-Based Stress Reduction (MBSR)
Structured MBSR programmes — typically eight weeks of guided mindfulness practice — have RCT evidence specifically in menopausal women for reducing anxiety, improving sleep, and decreasing the psychological burden of hot flashes. Like CBT, MBSR doesn't necessarily reduce the number of hot flashes, but consistently reduces how distressing and disruptive they feel, which is a clinically meaningful outcome. It also addresses the elevated cortisol patterns common in perimenopause that can amplify symptoms across the board.
Acupuncture
Acupuncture sits in a complicated evidence space — individual RCTs show benefit for hot flashes and sleep disturbance, but results are inconsistent across trials and hard to fully separate from placebo effects due to the challenge of blinding. A 2019 BMJ Open paper involving over 200 women found significant reductions in hot flash frequency and menopause-related discomfort after an eight-week acupuncture course. Given its low risk profile and the fact that some women experience meaningful relief, it earns a place on an honest evidence list — with the important caveat that the evidence is genuinely mixed rather than conclusive.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.